Financial reports
ARS
2023 FY
Annual report to shareholders
23 Apr 24
10-K
2023 FY
Annual report
21 Feb 24
10-Q
2023 Q3
Quarterly report
7 Nov 23
10-Q
2023 Q2
Quarterly report
7 Aug 23
10-Q
2023 Q1
Quarterly report
9 May 23
ARS
2022 FY
Annual report to shareholders
25 Apr 23
10-K
2022 FY
Annual report
28 Feb 23
10-Q
2022 Q3
Quarterly report
2 Nov 22
10-Q
2022 Q2
Quarterly report
3 Aug 22
10-Q
2022 Q1
Quarterly report
9 May 22
Current reports
8-K
Arcus Biosciences Reports Fourth-Quarter and Full-Year 2023 Financial Results and Provides a Pipeline Update
21 Feb 24
8-K
Entry into a Material Definitive Agreement
30 Jan 24
8-K
Arcus Biosciences Reports Third Quarter 2023 Financial Results and Provides a Pipeline Update
7 Nov 23
8-K
Arcus Biosciences Reports Second-Quarter 2023 Financial Results and Provides a Pipeline Update
7 Aug 23
8-K
Entry into a Material Definitive Agreement
28 Jun 23
8-K
Submission of Matters to a Vote of Security Holders
16 Jun 23
8-K
Regulation FD Disclosure
5 Jun 23
8-K
Entry into a Material Definitive Agreement
15 May 23
8-K
Arcus Biosciences Reports First Quarter 2023 Financial Results and Provides a Pipeline Update
9 May 23
8-K
Departure of Directors or Certain Officers
10 Mar 23
Registration and prospectus
S-3ASR
Automatic shelf registration
21 Feb 24
S-8
Registration of securities for employees
21 Feb 24
S-3ASR
Automatic shelf registration
28 Feb 23
S-8
Registration of securities for employees
28 Feb 23
S-3ASR
Automatic shelf registration
11 Oct 22
S-8
Registration of securities for employees
23 Feb 22
S-8
Registration of securities for employees
25 Feb 21
424B5
Prospectus supplement for primary offering
29 May 20
424B5
Prospectus supplement for primary offering
27 May 20
S-3ASR
Automatic shelf registration
27 May 20
Proxies
DEFA14A
Additional proxy soliciting materials
23 Apr 24
DEF 14A
Definitive proxy
23 Apr 24
DEFA14A
Additional proxy soliciting materials
21 Apr 23
DEF 14A
Definitive proxy
21 Apr 23
DEFA14A
Additional proxy soliciting materials
20 Apr 22
DEF 14A
Definitive proxy
20 Apr 22
DEFA14A
Additional proxy soliciting materials
20 Apr 21
DEF 14A
Definitive proxy
20 Apr 21
DEFA14A
Additional proxy soliciting materials
26 May 20
DEFA14A
Additional proxy soliciting materials
21 Apr 20
Other
UPLOAD
Letter from SEC
7 Jun 22
CORRESP
Correspondence with SEC
3 Jun 22
UPLOAD
Letter from SEC
10 May 22
EFFECT
Notice of effectiveness
26 Apr 19
CORRESP
Correspondence with SEC
23 Apr 19
CT ORDER
Confidential treatment order
16 Nov 18
CT ORDER
Confidential treatment order
15 Mar 18
UPLOAD
Letter from SEC
15 Mar 18
EFFECT
Notice of effectiveness
14 Mar 18
CERT
Certification of approval for exchange listing
12 Mar 18
Ownership
4
Jennifer Jarrett
29 Mar 24
144
Notice of proposed sale of securities
27 Mar 24
4
Jennifer Jarrett
20 Mar 24
144
Notice of proposed sale of securities
15 Mar 24
4
Jennifer Jarrett
28 Feb 24
4
Juan C. Jaen
28 Feb 24
4/A
II Robert C. Goeltz
23 Feb 24
SC 13G/A
VANGUARD GROUP INC
13 Feb 24
SC 13G
FMR LLC
9 Feb 24
3
Johanna Mercier
7 Feb 24